We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
The current GS71 market cap is 66.51B. The company's latest EPS is GBP 1.1889 and P/E is 11.34.
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| GBP (£) | GBP (£) | GBP (£) | GBP (£) | GBP (£) | |
| Total Revenue | 33.75B | 34.1B | 34.11B | 34.91B | 30.33B |
| Operating Income | 6.24B | 5.08B | 6.67B | 8.43B | 7.35B |
| Net Income | 4.65B | 5.75B | 4.39B | 14.96B | 4.93B |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| GBP (£) | GBP (£) | GBP (£) | GBP (£) | GBP (£) | |
| Total Assets | 79.69B | 80.43B | 79.1B | 60.15B | 59.01B |
| Total Liabilities | 61.34B | 59.62B | 57.76B | 50.05B | 46.21B |
| Total Equity | 18.36B | 20.81B | 21.34B | 10.1B | 12.8B |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| GBP (£) | GBP (£) | GBP (£) | GBP (£) | GBP (£) | |
| Operating | 8.02B | 8.44B | 7.95B | 7.4B | 6.77B |
| Investing | -5.35B | 2.16B | -1.78B | -8.77B | -1.6B |
| Financing | -1.84B | -10.13B | -7.59B | 823M | -5.64B |
| Market Cap | 66.51B |
| Price to Earnings Ratio | 11.34 |
| Price to Sales Ratio | 1.84 |
| Price to Cash Ratio | 19.04 |
| Price to Book Ratio | 4.37 |
| Dividend Yield | 3.14% |
| Shares Outstanding | 4.15B |
| Average Volume (1 week) | 19.22k |
| Average Volume (1 Month) | 23.03k |
| 52 Week Change | -12.21% |
| 52 Week High | 21.26 |
| 52 Week Low | 15.555 |
| Spread (Intraday) | 0.14 (0.84%) |
| Company Name | GSK Plc |
| Address |
79 new oxford street london WC1A 1DG |
| Website | https://www.gsk.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
